These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36411573)

  • 1. Antimalarials Targeting the Malaria Parasite Cation ATPase
    Zagórska A; Jaromin A
    Curr Top Med Chem; 2023; 23(3):214-226. PubMed ID: 36411573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs.
    Mohring F; van Schalkwyk DA; Henrici RC; Blasco B; Leroy D; Sutherland CJ; Moon RW
    mBio; 2022 Oct; 13(5):e0117822. PubMed ID: 36190127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs.
    Spillman NJ; Kirk K
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):149-62. PubMed ID: 26401486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization and chemical inhibition of PfATP4-associated Na
    Rosling JEO; Ridgway MC; Summers RL; Kirk K; Lehane AM
    J Biol Chem; 2018 Aug; 293(34):13327-13337. PubMed ID: 29986883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials.
    Spillman NJ; Allen RJ; McNamara CW; Yeung BK; Winzeler EA; Diagana TT; Kirk K
    Cell Host Microbe; 2013 Feb; 13(2):227-37. PubMed ID: 23414762
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Barnes CBG; Dans MG; Jonsdottir TK; Crabb BS; Gilson PR
    Front Cell Infect Microbiol; 2022; 12():1060202. PubMed ID: 36530423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A G358S mutation in the Plasmodium falciparum Na
    Qiu D; Pei JV; Rosling JEO; Thathy V; Li D; Xue Y; Tanner JD; Penington JS; Aw YTV; Aw JYH; Xu G; Tripathi AK; Gnadig NF; Yeo T; Fairhurst KJ; Stokes BH; Murithi JM; Kümpornsin K; Hasemer H; Dennis ASM; Ridgway MC; Schmitt EK; Straimer J; Papenfuss AT; Lee MCS; Corry B; Sinnis P; Fidock DA; van Dooren GG; Kirk K; Lehane AM
    Nat Commun; 2022 Sep; 13(1):5746. PubMed ID: 36180431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4.
    Turner H
    Future Med Chem; 2016; 8(2):227-38. PubMed ID: 26824174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials.
    Flannery EL; McNamara CW; Kim SW; Kato TS; Li F; Teng CH; Gagaring K; Manary MJ; Barboa R; Meister S; Kuhen K; Vinetz JM; Chatterjee AK; Winzeler EA
    ACS Chem Biol; 2015 Feb; 10(2):413-20. PubMed ID: 25322084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic responses in blood-stage malaria parasites associated with increased and decreased sensitivity to PfATP4 inhibitors.
    Tewari SG; Elahi R; Kwan B; Rajaram K; Bhatnagar S; Reifman J; Prigge ST; Vaidya AB; Wallqvist A
    Malar J; 2023 Feb; 22(1):56. PubMed ID: 36788578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic Consequences of Reducing Erythrocyte Membrane Cholesterol on Plasmodium falciparum.
    Ahiya AI; Bhatnagar S; Morrisey JM; Beck JR; Vaidya AB
    Microbiol Spectr; 2022 Feb; 10(1):e0015822. PubMed ID: 35196803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional permeabilization of the P. falciparum plasma membrane in infected cells links cation influx to reduced membrane integrity.
    Sylla M; Gupta A; Shao J; Desai SA
    PLoS One; 2023; 18(4):e0283776. PubMed ID: 37014920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4.
    Ashton TD; Dans MG; Favuzza P; Ngo A; Lehane AM; Zhang X; Qiu D; Chandra Maity B; De N; Schindler KA; Yeo T; Park H; Uhlemann AC; Churchyard A; Baum J; Fidock DA; Jarman KE; Lowes KN; Baud D; Brand S; Jackson PF; Cowman AF; Sleebs BE
    J Med Chem; 2023 Mar; 66(5):3540-3565. PubMed ID: 36812492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum.
    Vaidya AB; Morrisey JM; Zhang Z; Das S; Daly TM; Otto TD; Spillman NJ; Wyvratt M; Siegl P; Marfurt J; Wirjanata G; Sebayang BF; Price RN; Chatterjee A; Nagle A; Stasiak M; Charman SA; Angulo-Barturen I; Ferrer S; Belén Jiménez-Díaz M; Martínez MS; Gamo FJ; Avery VM; Ruecker A; Delves M; Kirk K; Berriman M; Kortagere S; Burrows J; Fan E; Bergman LW
    Nat Commun; 2014 Nov; 5():5521. PubMed ID: 25422853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4.
    Gilson PR; Kumarasingha R; Thompson J; Zhang X; Penington JS; Kalhor R; Bullen HE; Lehane AM; Dans MG; de Koning-Ward TF; Holien JK; Soares da Costa TP; Hulett MD; Buskes MJ; Crabb BS; Kirk K; Papenfuss AT; Cowman AF; Abbott BM
    Sci Rep; 2019 Jul; 9(1):10292. PubMed ID: 31311978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse chemotypes disrupt ion homeostasis in the Malaria parasite.
    Lehane AM; Ridgway MC; Baker E; Kirk K
    Mol Microbiol; 2014 Oct; 94(2):327-39. PubMed ID: 25145582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Product Inspired Novel Indole based Chiral Scaffold Kills Human Malaria Parasites via Ionic Imbalance Mediated Cell Death.
    Dangi P; Jain R; Mamidala R; Sharma V; Agarwal S; Bathula C; Thirumalachary M; Sen S; Singh S
    Sci Rep; 2019 Nov; 9(1):17785. PubMed ID: 31780808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Swelling Induced by the Antimalarial KAE609 (Cipargamin) and Other PfATP4-Associated Antimalarials.
    Dennis ASM; Lehane AM; Ridgway MC; Holleran JP; Kirk K
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.